Arunjyoti Bio Ventures Share Price
Sector: Personal & Household Prods.
8.40 +0.10 (1.20%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
8.02
Today’s High
8.50
52 Week Low
6.19
52 Week High
20.96
Key Metrics
- Market Cap (In Cr) 156.56
- Beta -0.97
- Div. Yield (%) 0
- P/B 9.73
- TTM P/E 32.83
- Peg Ratio -
- Sector P/E 0
- Open Price 8.1
- Prev Close 8.3
Arunjyoti Bio Ventures Analysis
Price Analysis
-
1 Week-3.49%
-
3 Months-41.88%
-
6 Month-36.57%
-
YTD-58.87%
-
1 Year0.99%
Risk Meter
- 60% Low risk
- 60% Moderate risk
- 60% Balanced Risk
- 60% High risk
- 60% Extreme risk
Arunjyoti Bio Ventures Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 20.47
- Selling/ General/ Admin Expenses Total
- 4.43
- Depreciation/ Amortization
- 2.01
- Other Operating Expenses Total
- 4.71
- Total Operating Expense
- 19.67
- Operating Income
- 0.79
- Net Income Before Taxes
- -1.3
- Net Income
- -0.35
- Diluted Normalized EPS
- -0.17
- Period
- 2024
- Total Assets
- 53.99
- Total Liabilities
- 52.22
- Total Equity
- 1.77
- Tangible Book Valueper Share Common Eq
- 0.85
- Period
- 2024
- Cashfrom Operating Activities
- 6.31
- Cashfrom Investing Activities
- -23.29
- Cashfrom Financing Activities
- 17.04
- Net Changein Cash
- 0.06
- Period
- 2023
- Total Revenue
- 1.83
- Selling/ General/ Admin Expenses Total
- 0
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.07
- Total Operating Expense
- 1.56
- Operating Income
- 0.27
- Net Income Before Taxes
- 0.27
- Net Income
- 0.22
- Diluted Normalized EPS
- 0.02
- Period
- 2023
- Total Assets
- 35.91
- Total Liabilities
- 33.79
- Total Equity
- 2.12
- Tangible Book Valueper Share Common Eq
- 0.19
- Period
- 2023
- Cashfrom Operating Activities
- -13.07
- Cashfrom Investing Activities
- -19.19
- Cashfrom Financing Activities
- 32.27
- Net Changein Cash
- 0.02
- Period
- 2022
- Total Revenue
- 3.25
- Selling/ General/ Admin Expenses Total
- 0.06
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.23
- Total Operating Expense
- 3.17
- Operating Income
- 0.08
- Net Income Before Taxes
- 0.08
- Net Income
- 0.06
- Diluted Normalized EPS
- 0
- Period
- 2022
- Total Assets
- 2.1
- Total Liabilities
- 0.09
- Total Equity
- 2
- Tangible Book Valueper Share Common Eq
- 0.18
- Period
- 2022
- Cashfrom Operating Activities
- -0.78
- Cashfrom Investing Activities
- 0
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.78
- Period
- 2021
- Total Revenue
- 5.51
- Selling/ General/ Admin Expenses Total
- 0.24
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.37
- Total Operating Expense
- 5.42
- Operating Income
- 0.09
- Net Income Before Taxes
- 0.09
- Net Income
- 0.07
- Diluted Normalized EPS
- 0.01
- Period
- 2021
- Total Assets
- 4.7
- Total Liabilities
- 2.76
- Total Equity
- 1.95
- Tangible Book Valueper Share Common Eq
- 0.17
- Period
- 2021
- Cashfrom Operating Activities
- -0.31
- Cashfrom Investing Activities
- 0
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.31
- Period
- 2020
- Total Revenue
- 7.31
- Selling/ General/ Admin Expenses Total
- 0.31
- Other Operating Expenses Total
- 0.78
- Total Operating Expense
- 7.18
- Operating Income
- 0.13
- Net Income Before Taxes
- 0.13
- Net Income
- 0.11
- Diluted Normalized EPS
- 0.01
- Period
- 2020
- Total Assets
- 5.9
- Total Liabilities
- 4.03
- Total Equity
- 1.87
- Tangible Book Valueper Share Common Eq
- 0.17
- Period
- 2020
- Cashfrom Operating Activities
- 0.77
- Cashfrom Investing Activities
- 0
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.77
- Period
- 2019
- Total Revenue
- 3.72
- Selling/ General/ Admin Expenses Total
- 0.43
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.1
- Total Operating Expense
- 3.68
- Operating Income
- 0.04
- Net Income Before Taxes
- 0.04
- Net Income
- 0.04
- Diluted Normalized EPS
- 0
- Period
- 2019
- Total Assets
- 5.48
- Total Liabilities
- 3.71
- Total Equity
- 1.77
- Tangible Book Valueper Share Common Eq
- 0.16
- Period
- 2019
- Cashfrom Operating Activities
- -2.71
- Cashfrom Investing Activities
- 0
- Cashfrom Financing Activities
- -0.19
- Net Changein Cash
- -2.9
- Period
- 2024-12-31
- Total Revenue
- 6.21
- Selling/ General/ Admin Expenses Total
- 2.44
- Depreciation/ Amortization
- 0.78
- Other Operating Expenses Total
- 1.94
- Total Operating Expense
- 6.59
- Operating Income
- -0.38
- Net Income Before Taxes
- -1.03
- Net Income
- -1.12
- Diluted Normalized EPS
- -0.07
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 6.46
- Selling/ General/ Admin Expenses Total
- 2.62
- Depreciation/ Amortization
- 0.74
- Other Operating Expenses Total
- 1.87
- Total Operating Expense
- 6.31
- Operating Income
- 0.15
- Net Income Before Taxes
- -0.52
- Net Income
- -0.41
- Diluted Normalized EPS
- -0.04
- Period
- 2024-09-30
- Total Assets
- 63.81
- Total Liabilities
- 27.17
- Total Equity
- 36.64
- Tangible Book Valueper Share Common Eq
- 1.97
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -4.31
- Cashfrom Investing Activities
- -2.46
- Cashfrom Financing Activities
- 7.37
- Net Changein Cash
- 0.6
- Period
- 2024-06-30
- Total Revenue
- 10.2
- Selling/ General/ Admin Expenses Total
- 1.37
- Depreciation/ Amortization
- 0.72
- Other Operating Expenses Total
- 2.59
- Total Operating Expense
- 7.28
- Operating Income
- 2.92
- Net Income Before Taxes
- 2.25
- Net Income
- 1.69
- Diluted Normalized EPS
- 0.11
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 8.66
- Selling/ General/ Admin Expenses Total
- 1.72
- Depreciation/ Amortization
- 0.81
- Other Operating Expenses Total
- 1.99
- Total Operating Expense
- 8.27
- Operating Income
- 0.39
- Net Income Before Taxes
- -0.41
- Net Income
- 1.26
- Diluted Normalized EPS
- 0.61
- Period
- 2024-03-31
- Total Assets
- 53.99
- Total Liabilities
- 52.22
- Total Equity
- 1.77
- Tangible Book Valueper Share Common Eq
- 0.85
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 6.31
- Cashfrom Investing Activities
- -23.29
- Cashfrom Financing Activities
- 17.04
- Net Changein Cash
- 0.06
- Period
- 2023-12-31
- Total Revenue
- 5.79
- Selling/ General/ Admin Expenses Total
- 1.53
- Depreciation/ Amortization
- 0.67
- Other Operating Expenses Total
- 1.28
- Total Operating Expense
- 4.64
- Operating Income
- 1.15
- Net Income Before Taxes
- 0.44
- Net Income
- -0.28
- Diluted Normalized EPS
- -0.02
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Arunjyoti Bio Ventures Technical
Moving Average
SMA
- 5 Day8.34
- 10 Day8.41
- 20 Day8.98
- 50 Day11.71
- 100 Day14.19
- 300 Day13.03
Arunjyoti Bio Ventures Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Prime Fresh
- 155
- 0
- 0
- 254
- 106.35
- 211.5
- Pee Cee Cosma Sope
- 542.95
- -125.55
- -18.78
- 978.6
- 383.89
- 143.21
- Arunjyoti Bio Ventures
- 8.4
- 0.1
- 1.2
- 20.96
- 6.19
- 156.56
- Jhs Svendgaard Laboratories
- 14.3
- -0.46
- -3.12
- 32.9
- 11.12
- 122.42
- Excel Realty N Infra
- 0.76
- 0
- 0
- 1.86
- 0.52
- 107.21
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Prime Fresh
- 30.93
- 3.47
- 16.39
- 4.43
- Pee Cee Cosma Sope
- 15.72
- 4.12
- 15.4
- 4.24
- Arunjyoti Bio Ventures
- -
- 9.62
- 1.06
- 0.27
- Jhs Svendgaard Laboratories
- -
- 0.71
- -2.71
- -5.81
- Excel Realty N Infra
- 107.87
- 0.61
- -0.61
- -14.99
Arunjyoti Bio Ventures Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 07-Apr-25
- Bonus issue
- 24-Mar-25
- Bonus issue
- 27-Jan-25
- Quarterly Results
- 11-Dec-24
- Stock Split & Others
- 12-Nov-24
- Quarterly Results
- 12-Aug-24
- Quarterly Results
- 30-May-24
- Audited Results
- 10-Feb-24
- Quarterly Results
- 31-Oct-23
- Quarterly Results
- 25-Jul-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 06-Jan-25
- 16-Dec-24
- EGM
- 14-Sept-24
- 12-Aug-24
- AGM
- 27-Nov-23
- 03-Nov-23
- EGM
- 29-Sept-23
- 20-Sept-23
- AGM
- 17-Jul-23
- 23-Jun-23
- EGM
- 15-Jul-22
- 20-Jun-22
- EGM
- 27-Sept-21
- 09-Aug-21
- AGM


- Ex-Splits
- Old FV
- New FV
- Description
- 17-Jan-25
- 10
- 1
- Stock split from Rs. 10/- to Re. 1/-.
- Announced on
- Record Date
- Ex-Rights Date
- Ratio
- FV
- Premium
- Description
- 14-Apr-23
- 12-Mar-24
- 12-Mar-24
- 8:1
- 10
- 10
- Rights issue of equity shares of Rs. 10/- in the ratio of 8:1 @ premium of Rs. 10/-.